PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 153 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $13,071,000 | -64.8% | 285,091 | -54.5% | 1.41% | -1.9% |
Q2 2018 | $37,084,000 | +29.1% | 626,950 | +48.6% | 1.43% | +25.9% |
Q1 2018 | $28,715,000 | +228.5% | 421,966 | +322.0% | 1.14% | +578.0% |
Q2 2017 | $8,740,000 | -48.5% | 100,000 | -78.1% | 0.17% | -61.6% |
Q1 2017 | $16,967,000 | +23.2% | 456,097 | +1.7% | 0.44% | +64.9% |
Q4 2016 | $13,768,000 | -21.3% | 448,471 | -23.6% | 0.26% | -24.3% |
Q2 2016 | $17,490,000 | +319.8% | 587,126 | +1367.8% | 0.35% | +79.5% |
Q1 2014 | $4,166,000 | – | 40,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |